Publications by authors named "John Wikstrand"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

846

Total Likes

139

Extended Reach

426,918

Social Features

39
I
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure.
Dipak Kotecha, Simrat K Gill, Marcus D Flather, Jane Holmes, Milton Packer, John Wikstrand

J Am Coll Cardiol· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment with insulin is associated with worse outcome in patients with chronic heart failure and diabetes.
Franco Cosmi, Li Shen, Michela Magnoli, William T Abraham, Inder S Anand, John Wikstrand

Eur J Heart Fail· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials.
John G F Cleland, Karina V Bunting, Marcus D Flather, Douglas G Altman, Jane Holmes, John Wikstrand

Eur Heart J· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure.
Dipak Kotecha, Marcus D Flather, Douglas G Altman, Jane Holmes, Giuseppe Rosano, John Wikstrand

J Am Coll Cardiol· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low YKL-40 in chronic heart failure may predict beneficial effects of statins: analysis from the controlled rosuvastatin multinational trial in heart failure (CORONA).
Fizza Arain, Lars Gullestad, Ståle Nymo, John Kjekshus, John G Cleland, John Wikstrand

Biomarkers· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Limited Added Value of Circulating Inflammatory Biomarkers in Chronic Heart Failure.
Ståle H Nymo, Pål Aukrust, John Kjekshus, John J V McMurray, John G F Cleland, John Wikstrand

JACC Heart Fail· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis.
Dipak Kotecha, Luis Manzano, Henry Krum, Giuseppe Rosano, Jane Holmes, John Wikstrand

BMJ· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loop diuretics, renal function and clinical outcome in patients with heart failure and reduced ejection fraction.
Kevin Damman, John Kjekshus, John Wikstrand, John G F Cleland, Michel Komajda

Eur J Heart Fail· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter Regarding Article, "Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.".
Azmil H Abdul-Rahim, Ana-Cristina Perez, Rachael L Fulton, Pardeep S Jhund, Roberto Latini, John Wikstrand

Circulation· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of endostatin in chronic heart failure patients with poor kidney function.
Thor Ueland, Pål Aukrust, Ståle H Nymo, John Kjekshus, John J V McMurray, John Wikstrand

Cardiology· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF.
Matthew J Feinstein, Pardeep Jhund, Joseph Kang, Hongyan Ning, Aldo Maggioni, John Wikstrand

Eur J Heart Fail· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk of Stroke in Chronic Heart Failure Patients Without Atrial Fibrillation: Analysis of the Controlled Rosuvastatin in Multinational Trial Heart Failure (CORONA) and the Gruppo Italiano per lo Studio della Sopravvivenza nell'Insufficienza Cardiaca-Heart Failure (GISSI-HF) Trials.
Azmil H Abdul-Rahim, Ana-Cristina Perez, Rachael L Fulton, Pardeep S Jhund, Roberto Latini, John Wikstrand

Circulation· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telomere length and outcomes in ischaemic heart failure: data from the COntrolled ROsuvastatin multiNAtional Trial in Heart Failure (CORONA).
Vincent G Haver, Irene Mateo Leach, John Kjekshus, Jayne C Fox, Hans Wedel, John Wikstrand

Eur J Heart Fail· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel extracellular matrix biomarkers as predictors of adverse outcome in chronic heart failure: association between biglycan and response to statin therapy in the CORONA trial.
Thor Ueland, Pål Aukrust, Ståle H Nymo, John Kjekshus, John J V McMurray, John Wikstrand

J Card Fail· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of outcomes after hospitalization for worsening heart failure, myocardial infarction, and stroke in patients with heart failure and reduced and preserved ejection fraction.
Søren L Kristensen, Pardeep S Jhund, Lars Køber, David Preiss, John Kjekshus, John Wikstrand

Eur J Heart Fail· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction.
Søren L Kristensen, Lars Køber, Pardeep S Jhund, Scott D Solomon, John Kjekshus, John Wikstrand

Circulation· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between angina pectoris and outcomes in patients with heart failure and reduced ejection fraction: an analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
Athar A Badar, Ana Cristina Perez-Moreno, Pardeep S Jhund, Chih M Wong, Nathaniel M Hawkins, John Wikstrand

Eur Heart J· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of coronary artery disease risk loci on ischemic heart failure severity and prognosis: association analysis in the COntrolled ROsuvastatin multiNAtional trial in heart failure (CORONA).
Vincent G Haver, Niek Verweij, John Kjekshus, Jayne C Fox, Hans Wedel, John Wikstrand

BMC Med Genet· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA Trial (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Jennifer K Rogers, Pardeep S Jhund, Ana-Cristina Perez, Michael Böhm, John G Cleland, John Wikstrand

JACC Heart Fail· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatigue as a predictor of outcome in patients with heart failure: analysis of CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Ana Cristina Perez-Moreno, Pardeep S Jhund, Michael R Macdonald, Mark C Petrie, John G F Cleland, John Wikstrand

JACC Heart Fail· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thyroid-stimulating hormone and clinical outcomes: the CORONA trial (controlled rosuvastatin multinational study in heart failure).
Ana Cristina Perez, Pardeep S Jhund, David J Stott, Lars Gullestad, John G F Cleland, John Wikstrand

JACC Heart Fail· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA.
Ståle H Nymo, Johannes Hulthe, Thor Ueland, John McMurray, John Wikstrand

Eur J Heart Fail· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic effect of high-sensitive troponin T assessment in elderly patients with chronic heart failure: results from the CORONA trial.
Jørgen Gravning, Erik T Askevold, Ståle H Nymo, Thor Ueland, John Wikstrand

Circ Heart Fail· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic value of CXCL16 in patients with left ventricular systolic dysfunction and heart failure.
Christen Peder Dahl, Pål Aukrust, Ståle H Nymo, John Kjekshus, John G F Cleland, John Wikstrand

Int J Cardiol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis